New studies into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are revealing promising outcomes in treating excess mass and diabetes 2 disease. Initial data suggest a distinct process contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/